{"success":true,"data":{"pressRelease":{"id":"162473","rtpr_id":"nGNEb8HSnq-20261006","ticker":"ALCLS","exchange":"Euronext Paris","all_tickers":["ALCLS"],"title":"REG-Monthly information on share capital and company voting rights","author":"Globe Newswire","published_at":"2026-10-06T20:30:00.211Z","article_body":"(Article 223-16 of General Regulation of the French financial markets\nauthority)\n\nPARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) --\n\nListing market: Euronext Growth\n\nISIN code: FR0010425595\n\n Date        Total number of shares in the capital  Total number of voting rights  \n 09/30/2026  100,732,781                            105,563,044                    \n\nFor further information on Cellectis, please\ncontact:         \n\nMedia contacts:              \nPascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14\n33, media@cellectis.com  \nPatricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46\n93      \n    \nInvestor Relations contact:           \nArthur Stril, Chief Financial Officer & Chief Business\nOfficer, investors@cellectis.com   \n\nAttachment\n*     Voting_Rights_PR_Sept_2026_EN\n(https://ml.globenewswire.com/Resource/Download/975944f6-1e36-4520-bf59-32a10fb3d6d1)","article_body_html":"","raw_payload":{"data":{"id":"nGNEb8HSnq-20261006","title":"REG-Monthly information on share capital and company voting rights","author":"Globe Newswire","ticker":"ALCLS","created":"2026-10-06T20:30:00.211Z","tickers":["ALCLS"],"exchange":"Euronext Paris","article_body":"(Article 223-16 of General Regulation of the French financial markets\nauthority)\n\nPARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) --\n\nListing market: Euronext Growth\n\nISIN code: FR0010425595\n\n Date        Total number of shares in the capital  Total number of voting rights  \n 09/30/2026  100,732,781                            105,563,044                    \n\nFor further information on Cellectis, please\ncontact:         \n\nMedia contacts:              \nPascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14\n33, media@cellectis.com  \nPatricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46\n93      \n    \nInvestor Relations contact:           \nArthur Stril, Chief Financial Officer & Chief Business\nOfficer, investors@cellectis.com   \n\nAttachment\n*     Voting_Rights_PR_Sept_2026_EN\n(https://ml.globenewswire.com/Resource/Download/975944f6-1e36-4520-bf59-32a10fb3d6d1)"},"type":"article","timestamp":"2026-10-06T20:30:00.298978502Z","server_sent_at_ms":1791318600298},"received_at":"2026-10-06T20:30:00.348Z","source_url":null},"analysis":{"id":"150954","press_release_id":"162473","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Cellectis published its monthly share capital disclosure under Article 223-16 of the AMF General Regulation.\n\nAs of September 30, 2026, the company had 100,732,781 shares outstanding and 105,563,044 total voting rights.\n\nThis is a routine regulatory filing with no new strategic or financial information.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine monthly voting-rights disclosure -- suppress."},"keyFigures":{"customDimensions":{"as_of_date":"2026-09-30","total_shares":100732781,"total_voting_rights":105563044}},"quotedText":"","namedEntities":{"people":[{"name":"Pascalyne Wilson","role":"Director, Communications"},{"name":"Patricia Sosa Navarro","role":"Chief of Staff to the CEO"},{"name":"Arthur Stril","role":"Chief Financial Officer & Chief Business Officer"}],"products":[],"companies":[{"name":"Cellectis","ticker":"ALCLS"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine monthly share capital and voting rights disclosure required by French AMF regulation. No new financial, operational, or strategic information."},"tickerRelevance":{"others":[],"primary":"ALCLS"},"globalImportance":5,"audienceRelevance":8,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine-regulatory-disclosure","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Cellectis published its monthly share capital disclosure under Article 223-16 of the AMF General Regulation.\n\nAs of September 30, 2026, the company had 100,732,781 shares outstanding and 105,563,044 total voting rights.\n\nThis is a routine regulatory filing with no new strategic or financial information.","key_figures":{"customDimensions":{"as_of_date":"2026-09-30","total_shares":100732781,"total_voting_rights":105563044}},"named_entities":{"people":[{"name":"Pascalyne Wilson","role":"Director, Communications"},{"name":"Patricia Sosa Navarro","role":"Chief of Staff to the CEO"},{"name":"Arthur Stril","role":"Chief Financial Officer & Chief Business Officer"}],"products":[],"companies":[{"name":"Cellectis","ticker":"ALCLS"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-06T20:30:04.418Z","global_importance":5,"audience_relevance":8,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine-regulatory-disclosure","issuerAuthored":true}},"durationMs":4051,"modelName":"glm-5.3-flashx"}}